Financial Statements and Related Announcement::Full Yearly Results

Issuer & Securities

Issuer/ Manager
IX BIOPHARMA LTD.
Securities
IX BIOPHARMA LTD. - SG1BD9000009 - 42C
Stapled Security
No

Announcement Details

Announcement Title
Financial Statements and Related Announcement
Date &Time of Broadcast
23-Aug-2022 06:05:03
Status
New
Announcement Sub Title
Full Yearly Results
Announcement Reference
SG220823OTHRD4G2
Submitted By (Co./ Ind. Name)
Gwendolin Lee Soo Fern
Designation
Company Secretary
Description (Please provide a detailed description of the event in the box below - Refer to the Online help for the format)
Please see attached.

Additional Details

For Financial Period Ended
30/06/2022

Attachments

iX Biopharma Ltd 2H22 Final Clean 2022-08-23.pdf
Press Release - iX Biopharma Records Eightfold Rise in FY22 Revenue to S$14.4m - Final.pdf
Total size =735K